{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:26:31Z","timestamp":1774355191139,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"L'Initiative\/Expertise France","award":["21SANIN207"],"award-info":[{"award-number":["21SANIN207"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09532-7","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:35:00Z","timestamp":1771238100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of a combined tuberculosis case-finding, treatment and prevention strategy in Thailand: protocol for a pragmatic phase IV stepped-wedge cluster-randomised trial, the CaPThai study"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9891-9958","authenticated-orcid":false,"given":"Tamara","family":"Tovar Sanchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintana","family":"Ngamvithayapong-Yanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Grint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Beneteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarmwai","family":"Luangjna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayouba","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Lachenal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryline","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phalin","family":"Kamolwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Lienhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"9532_CR1","unstructured":"World Health Organization, Global TB report 2024. https:\/\/www.who.int\/publications\/i\/item\/9789240013131."},{"key":"9532_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30449-2","author":"B Marais","year":"2018","unstructured":"Marais B. Preventing tuberculosis in household contacts crucial to protect children and contain epidemic spread. Lancet Glob Health. 2018. https:\/\/doi.org\/10.1016\/S2214-109X(18)30449-2.","journal-title":"Lancet Glob Health"},{"key":"9532_CR3","unstructured":"WHO operational handbook on tuberculosis. Module 1: prevention - tuberculosis preventive treatment. Geneva: World Health Organization. 2020. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"9532_CR4","unstructured":"World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low and middle-income countries. WHO\/HTM\/TB\/2012.9. Geneva, WHO. 2012."},{"issue":"Suppl 3","key":"9532_CR5","first-page":"S333","volume":"7","author":"HL Riechler","year":"2003","unstructured":"Riechler HL. Contacts of tuberculosis patients in high-incidence countries. Int J Tuberc Lung Dis. 2003;7(Suppl 3):S333\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9979","key":"9532_CR6","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO\u2019s new end TB strategy. Lancet. 2015;385(9979):1799\u2013801.","journal-title":"Lancet"},{"key":"9532_CR7","doi-asserted-by":"publisher","first-page":"e1329","DOI":"10.1016\/S2214-109X(18)30401-7","volume":"6","author":"PJ Dodd","year":"2018","unstructured":"Dodd PJ, et al. Potential effect of household contact management on childhood tuberculosis: modelling study. Lancet Glob Health. 2018;6:e1329\u201338.","journal-title":"Lancet Glob Health"},{"key":"9532_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1700209","volume":"378","author":"GJ Fox","year":"2018","unstructured":"Fox GJ, Nhung NV, Sy DN, et al. Household-contact investigation for detection of tuberculosis in Vietnam. N Engl J Med. 2018;378:221\u20139.","journal-title":"N Engl J Med"},{"issue":"10","key":"9532_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13(10):e1002152.","journal-title":"PLoS Med"},{"issue":"2","key":"9532_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","volume":"99","author":"GW Comstock","year":"1974","unstructured":"Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974;99(2):131\u20138.","journal-title":"Am J Epidemiol"},{"issue":"22","key":"9532_CR11","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","volume":"372","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. N Engl J Med. 2015;372(22):2127\u201335.","journal-title":"N Engl J Med"},{"key":"9532_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1086\/595012","volume":"48","author":"AC Hesseling","year":"2009","unstructured":"Hesseling AC, Cotton MF, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis. 2009;48:108\u201314.","journal-title":"Clin Infect Dis"},{"key":"9532_CR13","unstructured":"Roadmap towards ending TB in children and adolescents. Geneva: World Health Organization. 2023. p. 8, 29. Licence: CC BY-NC-SA 3.0 IGO.\u00a0https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/e424cff9-d253-451e-9ded-b1ce4a5a7759\/content."},{"key":"9532_CR14","doi-asserted-by":"crossref","unstructured":"Alkolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;1:CD000171.","DOI":"10.1002\/14651858.CD000171.pub3"},{"key":"9532_CR15","doi-asserted-by":"crossref","unstructured":"The TEMPRANO ANRS 12136 Study Group. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808\u201322","DOI":"10.1056\/NEJMoa1507198"},{"key":"9532_CR16","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365:2155\u201366.","journal-title":"N Engl J Med"},{"key":"9532_CR17","unstructured":"Sterling TR, Benson CA, Scott N, et al. Three months of weekly rifapentine + INH for M. tuberculosis infection in HIV infected persons. Presented at the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014), Boston, March 3\u20136, 2014 (poster)."},{"key":"9532_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","volume":"380","author":"S Swindells","year":"2019","unstructured":"Swindells S, Ramchandani R, Gupta A, Benson CA, Leon-Cruz J, Mwelase N, et al. One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis. N Engl J Med. 2019;380:1001\u201311.","journal-title":"N Engl J Med"},{"key":"9532_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","volume":"169","author":"ME Villarino","year":"2015","unstructured":"Villarino ME, Scott NA, Weis SE, et al. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr. 2015;169:247\u201355.","journal-title":"JAMA Pediatr"},{"key":"9532_CR20","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1019","author":"HR Stagg","year":"2014","unstructured":"Stagg HR, Zenner D, Harris RJ, Munoz L, Lipman MC, Abubakar I. Treatment of latent tuberculosis infection \u2013 a network meta-analysis. Ann Intern Med. 2014. https:\/\/doi.org\/10.7326\/M14-1019.","journal-title":"Ann Intern Med"},{"key":"9532_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1549-4","volume":"16","author":"AL Stuurman","year":"2016","unstructured":"Stuurman AL, Vonk Noordegraaf-Schouten M, van Kessel F, Oordt-Speets AM, Sandgren A, van der Werf MJ. Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review. BMC Infect Dis. 2016;16:257.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"9532_CR22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-2838","volume":"141","author":"AT Cruz","year":"2018","unstructured":"Cruz AT, Starke JR. Completion rate and safety of tuberculosis infection treatment with shorter regimens. Pediatrics. 2018;141(2):e20172838. https:\/\/doi.org\/10.1542\/peds.2017-2838.","journal-title":"Pediatrics"},{"key":"9532_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1183\/09031936.00070812","volume":"41","author":"GJ Fox","year":"2013","unstructured":"Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2013;41:140\u201356.","journal-title":"Eur Respir J"},{"issue":"3","key":"9532_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2471\/BLT.19.239293","volume":"98","author":"W Imsanguan","year":"2020","unstructured":"Imsanguan W, Buppachat S, Wanchaithanawong V, et al. Contact tracing for tuberculosis, Thailand. Bull World Health Organ. 2020;98(3):212\u20138.","journal-title":"Bull World Health Organ"},{"key":"9532_CR25","unstructured":"National operational plan to end tuberculosis 2021\u20132023 - https:\/\/www.tbthailand.org\/documents.html."},{"key":"9532_CR26","unstructured":"Division of TB: National guidelines for TB preventive therapy. https:\/\/online.anyflip.com\/kqmza\/lnvw\/mobile\/index.html."},{"key":"9532_CR27","unstructured":"Division of TB: National guidelines for TB treatment: https:\/\/online.anyflip.com\/kqmza\/akkj\/mobile\/index.html."},{"key":"9532_CR28","unstructured":"United Nations Thematic Working Group on Migration in Thailand. Thailand migration report 2019. Edited by Benamin Harkins. https:\/\/thailand.un.org\/sites\/default\/files\/2020-06\/Thailand-Migration-Report-2019.pdf."},{"key":"9532_CR29","unstructured":"Yang J, Wang S, Dewina R. Taking the Pulse of Poverty and Inequality in Thailand. Washington, D.C.: World Bank Group; 2020 http:\/\/documents.worldbank.org\/curated\/en\/614661586924075867\/Taking-the-Pulse-of-Poverty-and-Inequality-in-Thailand."},{"key":"9532_CR30","unstructured":"WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"9532_CR31","unstructured":"WHO operational handbook on tuberculosis. Module 2: screening - systematic screening for tuberculosis disease. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"9532_CR32","unstructured":"Update of recommendations on first- and second-line antiretroviral regimens. Geneva, Switzerland: World Health Organization; 2019 (WHO\/CDS\/HIV\/19.15)."},{"key":"9532_CR33","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS. Division of AIDS (DAIDS) table for grading the severity of adult and paediatric adverse events, corrected version 2.1. [July 2017]. Available from: https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/daidsgradingcorrectedv21.pdf."},{"issue":"2","key":"9532_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"2","key":"9532_CR35","first-page":"203","volume":"14","author":"SC Cavalcante","year":"2010","unstructured":"Cavalcante SC, Durovni B, Barnes GL, et al. Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro. Brazil Int J Tuberc Lung Dis. 2010;14(2):203\u20139.","journal-title":"Brazil Int J Tuberc Lung Dis"},{"key":"9532_CR36","unstructured":"Cattamanchi. Digital adherence technology for tuberculosis treatment supervision: a stepped-wedge cluster-randomized trial in Uganda."},{"key":"9532_CR37","doi-asserted-by":"publisher","unstructured":"Degtiar I, Rose S. A review of generalizability and transportability. Annu Rev Stat Appl. 2023;10(1):501\u201324.\u00a0https:\/\/doi.org\/10.1146\/annurev-statistics-042522-103837.","DOI":"10.1146\/annurev-statistics-042522-103837"},{"key":"9532_CR38","doi-asserted-by":"publisher","unstructured":"Hemming K, Taljaard M, Grimshaw J. Introducing the new CONSORT extension for stepped-wedge cluster randomised trials. Trials. 2019;20(1):68. https:\/\/doi.org\/10.1186\/s13063-018-3116-3.\u00a0https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-3116-3.","DOI":"10.1186\/s13063-018-3116-3"},{"key":"9532_CR39","doi-asserted-by":"crossref","unstructured":"Le-Rademacher J, Gunn H, Yao X, Schaid DJ. Clinical trials overview: from explanatory to pragmatic clinical trials. InMayo Clinic Proceedings. 2023;98(8):1241\u201353. Elsevier.","DOI":"10.1016\/j.mayocp.2023.04.013"},{"key":"9532_CR40","doi-asserted-by":"crossref","unstructured":"Califf RM. Pragmatic clinical trials: Emerging challenges and new roles for statisticians. Clinical Trials. 2016;13(5):471\u20137.","DOI":"10.1177\/1740774516656944"},{"key":"9532_CR41","doi-asserted-by":"publisher","unstructured":"Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28(2):182\u201391. https:\/\/doi.org\/10.1016\/j.cct.2006.05.007.\u00a0Epub 2006 Jul 7. PMID: 16829207.","DOI":"10.1016\/j.cct.2006.05.007"},{"key":"9532_CR42","doi-asserted-by":"publisher","unstructured":"Kennedy-Shaffer L, de Gruttola V, Lipsitch M. Novel methods for the analysis of stepped wedge cluster randomized trials. Stat Med. 2020;39(7):815\u201344. https:\/\/doi.org\/10.1002\/sim.8451.\u00a0Epub 2019 Dec 26. PMID: 31876979; PMCID: PMC7247054.","DOI":"10.1002\/sim.8451"},{"key":"9532_CR43","doi-asserted-by":"publisher","unstructured":"Silkey M, Homan T, Maire N, Hiscox A, Mukabana R, Takken W, et al. Design of trials for interrupting the transmission of endemic pathogens. Trials. 2016;17(1):278. https:\/\/doi.org\/10.1186\/s13063-016-1378-1.\u00a0PMID: 27266269; PMCID: PMC4895826.","DOI":"10.1186\/s13063-016-1378-1"},{"key":"9532_CR44","doi-asserted-by":"publisher","unstructured":"Multerer L, Vanobberghen F, Glass TR, Hiscox A, Lindsay SW, Takken W, et al. Estimating intervention effectiveness in trials of malaria interventions with contamination. Malar J. 2021;20(1):413. https:\/\/doi.org\/10.1186\/s12936-021-03924-7.\u00a0PMID: 34670558; PMCID: PMC8527711.","DOI":"10.1186\/s12936-021-03924-7"},{"key":"9532_CR45","doi-asserted-by":"publisher","unstructured":"Shah L, Rojas M, Mori O, Zamudio C, Kaufman JS, Otero L, et al. Implementation of a stepped-wedge cluster randomized design in routine public health practice: design and application for a tuberculosis (TB) household contact study in a high burden area of Lima, Peru. BMC Public Health. 2015;15(1):587. https:\/\/doi.org\/10.1186\/s12889-015-1883-2.\u00a0PMID: 26109173; PMCID: PMC4481074.","DOI":"10.1186\/s12889-015-1883-2"},{"key":"9532_CR46","doi-asserted-by":"publisher","unstructured":"Viviani S, Carrieri P, Bah E, Hall AJ, Kirk GD, Mendy M, Montesano R, Plymoth A, Sam O, Van Der Sande M, Whittle H, Hainaut P, The Gambia Hepatitis Intervention Study. 20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomark Prev. 2008;17(11):3216\u201323. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0303.","DOI":"10.1158\/1055-9965.EPI-08-0303"},{"key":"9532_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1214066","volume":"11","author":"W Mutale","year":"2023","unstructured":"Mutale W, Ayles H, Lewis J, Bosompraph S, Chilengi R, Tembo MM, et al. Protocol-driven primary care and community linkage to reduce all-cause mortality in rural Zambia: a stepped-wedge cluster randomized trial. Front Public Health. 2023;11:1214066. https:\/\/doi.org\/10.3389\/fpubh.2023.1214066.","journal-title":"Front Public Health"},{"issue":"3","key":"9532_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1814556","volume":"381","author":"RJ Hayes","year":"2019","unstructured":"Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, et al. Effect of universal testing and treatment on HIV incidence\u2014HPTN 071 (PopART). N Engl J Med. 2019;381(3):207\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1814556.","journal-title":"N Engl J Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09532-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09532-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09532-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:28:20Z","timestamp":1774351700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09532-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9532"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09532-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Implementation of a new Strategic TB Case-Finding, Treatment and Prevention Public Health Pack in Thailand, CaPThai Study Protocol obtained the ethical initial approval by the Independent Ethics Committees of Thailand (CREC: Central Research Ethics Committee) No. COA-CREC108\/2023 on January 11th, 2024, and UK (EC-LSHTM: Ethics Committee of the London School of Hygiene & Tropical Medicine) No. 28336 on October 24th, 2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"A model consent form is available in Annex 1.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"225"}}